Description
+ Include: videos + file sub vtt + pdf, size: GB
+ Target Audience: Primary Care Physicians, Family Physicians, Internists, Gynecologists, Obstetricians and Gynecologists (OB-GYNs), Urologists, Urologic Oncologists, Endocrinologists
+ Sample video: contact me for sample video
+ Information:
-
Conference Title: Men’s & Women’s Health for Primary Care: Cardiology/Endocrinology/Gynecology/Men’s Urology
-
Organizer: Medical Education Resources (MER)
-
Dates: October 22–25, 2026
-
Location: Disneyland Resort, CA – Disney’s Grand Californian Hotel® & Spa
-
Participating Faculty:
-
Angela Leung, MD, MSc: Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, UCLA David Geffen School of Medicine; VA Greater Los Angeles Healthcare System, Los Angeles, California
-
Peter S. Marcus, MD: Director of Patient Quality & Safety at Women’s Hospital, St. Vincent’s Hospital, Department of Ob/Gyn, Indianapolis, Indiana; Volunteer Clinical Associate Professor, Indiana University School of Medicine
-
Ileana Piña, MD, MPH, FAHA, FACC: Professor of Medicine, Thomas Jefferson University; Clinical Professor of Medicine, Central Michigan University; Senior Staff Fellow, FDA, CDRH
-
Shandra Wilson, MD: Associate Professor, Urologic Oncology, University of Colorado Health; Chief of Surgery, Littleton Adventist Hospital, Denver, Colorado
-
Learning Objectives
Upon completion of this program, participants should be better able to:
-
Assess and manage abnormal uterine bleeding
-
Describe the management of abnormal pap smears and HPV
-
Discuss menopausal transition and the risks/benefits of treatment options
-
Discuss the current evidence and recommendations regarding breast cancer screening
-
Discuss medical management of male sexual health
-
Evaluate and manage sexually-transmitted infections in men
-
Differentiate between benign prostate conditions and prostate cancers
-
Discuss the biology and screening, and treatment options of prostate and testicular cancer
-
Describe the pathophysiology surrounding obesity and the risks and benefits of the various weight management options
-
Identify the risks of abnormal thyroid function
-
Identify the risks and benefits of utilizing bisphosphonates in the treatment of osteoporosis
-
Describe the diagnostic evaluation of thyroid nodules with a focus on the utilization of ultrasound and cytology
-
Implement lifestyle changes as well as lipid and cholesterol guidelines for the prevention of CAD
-
Describe the work-up, risk assessment and test selection of patients with suspected CAD
-
Implement treatment strategies reflective of recent guidelines and current evidence based medicine for heart failure
-
Describe current diagnostic and treatment approaches to arrhythmias and atrial fibrillation
Target Audience
This program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine.
Best for Primary Care Physicians, Family Physicians, Internists, Gynecologists, Obstetricians and Gynecologists (OB-GYNs), Urologists, Urologic Oncologists, Endocrinologists, Diabetologists, Obesity Medicine Specialists, Bariatric Surgeons, Cardiologists, Preventive Cardiologists, Lipidologists, Clinical Cardiac Electrophysiologists, Advanced Heart Failure and Transplant Cardiologists, Infectious Disease Specialists, Medical Oncologists, Breast Oncologists, Medical Geneticists, Rheumatologists, and Geriatricians.
Topics
THURSDAY, OCTOBER 22, 2026
-
7:00 am – 7:30 am: Check-In and Hot Breakfast
-
7:30 am – 8:30 am | Abnormal Uterine Bleeding — Peter S. Marcus, MD
-
Overview of normal/abnormal menstrual physiology/profile; Menstrual disturbances; Ovulatory and anovulatory uterine bleeding; Other menstrual abnormalities; Diagnosis and appropriate treatment options
-
-
8:30 am – 9:30 am | Abnormal Pap Smears and High Risk HPV — Peter S. Marcus, MD
-
Current recommendations for cervical cancer screening; Incorporating the ASCCP consensus guidelines for management of cytologic cervical abnormalities (including ASCUS, LGSIL, HGSIL and atypical glandular cells) into your practice; Algorithm for the appropriate use of HPV testing; History of HPV and effectiveness of its use; Recommendations for missed doses; Storage and administration of HPV vaccines
-
-
9:30 am – 9:40 am: Coffee Break
-
9:40 am – 10:40 am | Menopause Transition and Hormone Replacement Therapy — Peter S. Marcus, MD
-
Symptoms of menopause, including hot flashes, night sweats, and atrophy; Menopause syndromes, including osteoporosis, breast cancer, cardiac disease, and colon cancer; Estrogen analogs; Counseling patients in options and alternatives to hormone therapy; Designer estrogens; SERMs; HRTs; Discussion of risks and benefits, especially in breast cancer and CHD
-
-
10:40 am – 11:40 am | Androgen Replacement and Sexual Function — Shandra Wilson, MD
-
Treatment algorithm and safety profiles for the treatment of erectile dysfunction; testosterone supplementation for the treatment of ED or hypogonadism
-
-
11:40 am – 12:40 pm | Sexually Transmitted Infections in Men — Shandra Wilson, MD
-
Presenting symptoms, lesions, latencies, diagnostic work-ups and therapies of the common sexually transmitted diseases
-
-
12:40 pm: Session Adjourns
FRIDAY, OCTOBER 23, 2026
-
7:00 am – 7:30 am: Arrival and Hot Breakfast
-
7:30 am – 8:30 am | Benign Male Genitourinary Conditions — Shandra Wilson, MD
-
Appropriate primary medical management of lower urinary tract symptoms (LUTS) (also known as BPH) as well as identification of patients with complex or refractory cases that warrant referral; diagnosis and treatment of epididymitis, testicular pain, prostatitis and other benign findings
-
-
8:30 am – 9:30 am | Male Malignancies (Prostate & Testicular) — Shandra Wilson, MD
-
Biology and treatment options using current medical technology of prostate cancer; evaluation and treatment of testicular cancer and long-term ramifications after cure
-
-
9:30 am – 9:40 am: Coffee Break
-
9:40 am – 10:40 am | Breast Cancer Screening — Peter S. Marcus, MD
-
Comparison of recent breast cancer screening recommendations from U.S. Preventive Services Task Force, ACOG/ACS/NCCN, including a discussion of risks and benefits of screening at various ages; Review of the new USPSTF guideline on BRCA-related cancer: risk assessment, genetic counseling, and genetic testing, including risk assessment tools for women with a personal or family history of breast, ovarian and related cancers
-
-
10:40 am – 11:40 am | Top Questions in the Evaluation and Management of Obesity — Angela Leung, MD, MSc
-
Diagnosis; etiology; complications; use of appetite suppressant medications; lifestyle modifications; when surgery should be performed
-
-
11:40 am – 12:40 pm | Top Questions in the Evaluation and Management of Hypothyroidism — Angela Leung, MD, MSc
-
Prevalence, diagnosis and treatment options of hypothyroidism
-
-
12:40 pm: Session Adjourns
SATURDAY, OCTOBER 24, 2026
-
7:00 am – 7:30 am: Arrival and Hot Breakfast
-
7:30 am – 8:30 am | Top Questions in the Evaluation and Management of Osteoporosis — Angela Leung, MD, MSc
-
Review the epidemiology and pathophysiology of osteoporosis along with interpretation of DEXA scans and FRAX risk assessment; up-to-date therapeutic options
-
-
8:30 am – 9:30 am | Top Questions in the Evaluation and Management of Thyroid Nodules and Cancer — Angela Leung, MD, MSc
-
Diagnosis and treatment
-
-
9:30 am – 9:40 am: Coffee Break
-
9:40 am – 10:40 am | Primary Prevention of Cardiometabolic CVD — Ileana Piña, MD, MPH, FAHA, FACC
-
Definitions; AHA/ACC and other lipid guidelines updates; HDL Cholesterol: The good cholesterol?; Metabolic syndrome and/or obesity; Who needs treatment and how much; The role of lifestyle changes, exercise and cardiac rehabilitation; Drug therapy updates; Risk calculation; Role of pooled equations for risk estimates
-
-
10:40 am – 11:40 am | Work-up of Patients with Suspected CAD — Ileana Piña, MD, MPH, FAHA, FACC
-
Risk factor evaluation and risk assessment models; 2021 ACC/AHA Chest Pain Guidelines; Test selection including ECG, echo, nuclear and newer imaging modalities (including discussion of appropriate use criteria–AUC); The usefulness of CT scanning; The role of bio markers and EBCT; Suspected CAD in special populations (women, diabetics, the elderly)
-
-
11:40 am: Session Adjourns
SUNDAY, OCTOBER 25, 2026
-
7:00 am – 7:30 am: Arrival and Continental Breakfast
-
7:30 am – 8:30 am | Heart Failure — Ileana Piña, MD, MPH, FAHA, FACC
-
Etiologies and stages of heart failure; ACC/AHA Heart Failure Guidelines; Heart failure with reduced EF (HFrEF) and heart failure with preserved EF (HFpEF); Determining patients for referral using biomarkers, eg NT Pro BNP; Treatment options: ACE inhibitors, ARBs, ARNI, beta blockers, mineralocorticoid receptor antagonists, SGLT2i; The role of devices (ICD and/or CRT) in treatment and antiplatelet drugs; Issues related to the hospitalized patient with acute decompensated heart failure and readmissions
-
-
8:30 am – 9:30 am | Arrhythmias — Ileana Piña, MD, MPH, FAHA, FACC
-
Types and symptoms of arrhythmias; Approach to the patient: when to treat, when to refer, when to admit; Evaluation of the patient with palpitations; Atrial fibrillation: the use of anticoagulants indications, CVA risk scores, warfarin vs newer oral anticoagulants, controlling heart rate vs rhythm; Ventricular and other arrhythmias: when are they serious
-
-
9:30 am: Conference Adjourns





Reviews
There are no reviews yet.